Even though a large proportion of cancer patients carry genetic mutations that make them more susceptible to cancer, only a ...

The surge in genomics and proteomics research for disease diagnosis, drug discovery, and personalized medicine is a primary driver of the DNA microarray market. Applications in Disease Diagnostics: ...

Dublin, June 30, 2025 (GLOBE NEWSWIRE) -- The "Chromosomal Microarray Market Size, Share, Trends, Analysis, and Forecast 2025-2034 | Global Industry Growth, Competitive Landscape, Opportunities, and ...

Credit: Getty Images Determining the presence or absence of gene mutations associated with aggressive prostate cancer can have implications for risk stratification, monitoring, and therapy. Genetic ...

Each month, The Clinical Advisor makes one new clinical feature available ahead of print. Don’t forget to take the poll. The results will be published in the next month’s issue. Healthcare providers ...

Genetic factors significantly influence breast cancer risk, with up to 10% of cases being hereditary. Key risk factors include family history, genetic mutations such as BRCA1/BRCA2, and polygenic risk ...

Reportlinker.com announces that a new market research report is available in its catalogue: Microarray Marketshttp://www.reportlinker.com/p096372/Microarray-Markets ...

A recent study highlights how DNA microarray technology enables high-throughput gene analysis, supporting variation detection, expression profiling, and clinical research. By refining probe design and ...

Jill Martin is taking a cause close to her heart to "Football Night in America." Ahead of the Bengals-Giants game on Sunday, Oct. 13, Jill joined the program to discuss her history with breast cancer ...